Anne V. Yagolovich

Generation of new TRAIL mutants DR5-A and DR5-B with improved selectivity to death receptor 5

Marine E. Gasparian, Boris V. Chernyak, Anne V. Yagolovich et al. · APOPTOSIS · 2009 · 50 citations

Signal Transduction, Genetics, Receptor (Biochemistry) +5

Death Receptors DR4 and DR5 Undergo Spontaneous and Ligand-Mediated Endocytosis and Recycling Regardless of the Sensitivity of Cancer Cells to TRAIL

Artem A. Artykov, Anne V. Yagolovich, Daria B. Trushina et al. · Frontiers in Cell and Developmental Biology · 2021 · 38 citations · Full text

Apoptosis, Cell Death, Cancer Biology +18

Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase

Marine E. Gasparian, Valeriy G. Ostapchenko, Anne V. Yagolovich et al. · Biotechnology Letters · 2007 · 22 citations

Protein Secretion, Toxinology, Biochemistry +9

A New Efficient Method for Production of Recombinant Antitumor Cytokine TRAIL and Its Receptor-Selective Variant DR5-B

Anne V. Yagolovich, Artem A. Artykov, Marine E. Gasparian · Biochemistry (Moscow) · 2019 · 18 citations

Genetically Modified DR5-Specific TRAIL Variant DR5-B Revealed Dual Antitumor and Protumoral Effect in Colon Cancer Xenografts and an Improved Pharmacokinetic Profile

Anne V. Yagolovich, Artem A. Artykov, Alexander Andreev‐Andrievskiy et al. · Translational Oncology · 2020 · 16 citations · Full text

Chemoprevention Strategy, Opg Receptors, Colon Cancer Xenografts +19